Revance Therapeutics Inc (RVNC)
3.08
+0.01
(+0.33%)
USD |
NASDAQ |
Dec 20, 16:00
3.05
-0.03
(-0.97%)
After-Hours: 20:00
Revance Therapeutics Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Recursion Pharmaceuticals Inc | 3.298 |
| Regeneron Pharmaceuticals Inc | 2.63 |
| Ligand Pharmaceuticals Inc | 2.574 |
| MEI Pharma Inc | 0.6696 |
| Cellectar Biosciences Inc | 6.260 |
Price to Book Value Related Metrics
| PS Ratio | 1.160 |
| Price | 3.08 |
| Earnings Yield | -62.99% |
| Market Cap | 323.10M |